Braidwell LP Acquires 495,577 Shares of Acadia Healthcare Company, Inc. $ACHC

Braidwell LP boosted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 76.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,141,477 shares of the company’s stock after purchasing an additional 495,577 shares during the quarter. Braidwell LP owned 1.23% of Acadia Healthcare worth $33,708,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Federated Hermes Inc. boosted its stake in shares of Acadia Healthcare by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after buying an additional 668 shares during the period. Price T Rowe Associates Inc. MD grew its position in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after buying an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after buying an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its stake in Acadia Healthcare by 2.1% during the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after acquiring an additional 867 shares during the period.

Analyst Ratings Changes

Several equities analysts have weighed in on ACHC shares. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Barclays upped their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Finally, TD Cowen increased their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $27.75 on Thursday. The firm has a market capitalization of $2.58 billion, a price-to-earnings ratio of -2.23, a PEG ratio of 9.10 and a beta of 0.62. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The business’s 50-day moving average price is $30.64 and its 200-day moving average price is $26.42. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.